<DOC>
	<DOC>NCT01232439</DOC>
	<brief_summary>To measure the occupancy of brain kappa opioid receptors after single oral doses of LY2456302.</brief_summary>
	<brief_title>A Study of Brain Receptor Occupancy in Healthy Subjects</brief_title>
	<detailed_description />
	<mesh_term>Alcoholism</mesh_term>
	<mesh_term>Analgesics, Opioid</mesh_term>
	<criteria>Healthy male or female Have clinical laboratory tests within normal reference ranges Have arterial and venous access sufficient to allow blood sampling Currently enrolled in, or discontinued within the last 30 days from a clinical trial History of severe allergies or multiple adverse drug reactions Have an abnormal ECG at screening visit Have abnormal sitting blood pressure Have an increased risk of seizures Current suicidal ideation Positive test for HIV, hepatitis C, or hepatitis B Women who are breast feeding Smoke more than 10 cigarettes per day, or equivalent Drink more than 5 cups of coffee per day, or equivalent Have a history of head injury Unable to undergo a MRI Suffer from claustrophobia</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>May 2011</verification_date>
</DOC>